Shashank Deshpande | Boehringer Ingelheim BE

Shashank Deshpande

Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit

Credentials

Milestones

• Diplom-Kaufmann (Masters’ degree in Business Administration), University of Hamburg, Hamburg, Germany

Carrière professionnelle

• 2025 - Present
  Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit
• 2024 - Present
  Member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit
• 2024 - 2024
  Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit
• 2022 - 2023
  Country Managing Director, Japan
• 2020 - 2022
  Head of Human Pharma, Japan
• 2019 - 2020
  Head of Specialty Care, Japan
• 2017 - 2019
  Head of Marketing, Japan
• 2014 - 2017
  Head of Diabetes Marketing, Japan
• 2012 - 2014
  Global Brand Team Leader Trajenta® (Ingelheim, Germany)
• 2002 - 2012
  Various roles in US and Global Marketing at Sanofi, US
• 1999 - 2002
  Strategy consultant at Cap Gemini, Germany

Michael Schmelmer

Dr Paola Casarosa

Harsha Deshmukh

Frank Hübler

Dr Armin Wiesler

References